세계의 생명과학 애널리틱스 시장 보고서(2025년)
Life Science Analytics Global Market Report 2025
상품코드 : 1821574
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생명과학 애널리틱스 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 15.6%로 557억 달러로 성장합니다. 예측 기간의 성장은 원격의료의 채택, 인구 증가, 약물 재사용의 채택, 규제 개혁, 질병 감시 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 인공지능(AI)을 활용한 의약품 안전성, 진단의 예측 분석, 유전자 편집의 발전, 데이터 시각화 툴, 데이터 보안을 위한 블록체인 등이 있습니다.

향후 5년간 15.6%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 대만과 한국에서 조달하는 유전체 분석용 고성능 컴퓨팅 시스템의 비용을 상승시키고, 생물의학 발견을 지연시키고, 연구 인프라 비용을 상승시킴으로써 미국 연구기관을 저해할 것으로 예측됩니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

생명과학 분석 시장의 성장은 만성질환의 유병률 증가로 인해 촉진될 것으로 예측됩니다. 만성질환은 장기적으로 지속되는 특징이 있으므로 조기 발견과 개입을 위한 첨단 분석이 필요합니다. 생명과학 분석의 컴포넌트인 예측 분석은 만성질환 예방에 중요한 역할을 합니다. 국제당뇨병연맹(IDF)에 따르면 전 세계 당뇨병 인구는 2021년 약 5억 3,700만 명, 2030년 6억 4,300만 명, 2045년 7억 8,300만 명으로 증가할 것으로 예측됩니다. 이러한 만성질환의 유병률 증가는 생명과학 분석 시장 확대를 촉진하는 중요한 요인으로 작용하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Life science analytics is a field dedicated to the study and advancement of human life, playing a crucial role in comprehending diseases' nature and severity. It involves clinical data analysis, offering predictive tools to enhance patient care and safeguard both animal and human well-being.

Within the life science market, there are three primary types of analytics: descriptive, predictive, and prescriptive. Descriptive analytics involves manually examining data to answer questions about what has happened or is currently occurring. It encompasses traditional business intelligence tools like bar charts, pie charts, line graphs, tables, and narrative generation. This analytical approach utilizes software and services and can be deployed on-demand or on-premises. Its applications span across research and development, preclinical and clinical trials, sales and marketing, regulatory compliance, supply chain optimization, and pharmacovigilance. Various end-users, including medical devices, pharmaceuticals, biotechnology, and others, benefit from these analytics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The life science analytics market research report is one of a series of new reports from The Business Research Company that provides life science analytics market statistics, including life science analytics industry global market size, regional shares, competitors with a life science analytics market share, detailed life science analytics market segments, market trends and opportunities, and any further data you may need to thrive in the life science analytics industry. This life science analytics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The life science analytics market size has grown strongly in recent years. It will grow from $28.56 billion in 2024 to $31.24 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to pharmaceutical sales and marketing, healthcare cost reduction, global health preparedness, biopharmaceutical manufacturing, digital health adoption.

The life science analytics market size is expected to see rapid growth in the next few years. It will grow to $55.7 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to adoption of telemedicine, growth of population, adoption of drug repurposing, regulatory reforms, increasing disease surveillance. Major trends in the forecast period include artificial intelligence (AI)-enhanced drug safety, predictive analytics in diagnostics, gene editing advancements, data visualization tools, blockchain for data security.

The forecast of 15.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. research institutions by increasing the cost of high-performance computing systems for genomic analysis sourced from Taiwan and South Korea, thereby slowing biomedical discoveries and elevating research infrastructure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the life science analytics market is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by long-term persistence, necessitate advanced analytics for early detection and intervention. Predictive analytics, a component of life science analytics, plays a crucial role in chronic disease prevention. According to the International Diabetes Federation (IDF), the global diabetic population reached approximately 537 million adults in 2021, with projections indicating an increase to 643 million by 2030 and 783 million by 2045. This escalating prevalence of chronic diseases is a key factor driving the expansion of the life science analytics market.

The life science analytics market is expected to experience growth due to the rising demand for personalized medicine. Personalized medicine tailors medical treatments to an individual's unique genetic makeup, enhancing the effectiveness and precision of healthcare interventions. Life science analytics are integral to personalized medicine for various purposes, including drug discovery, biomarker identification, genomic and molecular data analysis, and clinical decision support. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. This surge in demand for personalized medicine is a significant driver of the life science analytics market.

A prominent trend in the life science analytics market is the adoption of technological advancements. Major companies in the sector are actively developing new technological solutions to strengthen their market position. For example, Charles River Associates introduced the healthcare claims analytics platform (HCAP) in July 2022. HCAP, a dynamic and modular data visualization tool, streamlines the analysis of patient, healthcare practitioner (HCP), and healthcare organization (HCO) data, enabling informed decision-making through insights and analytics. This focus on technological innovation is shaping the landscape of the life science analytics market.

Leading companies in the life science analytics market are concentrating on developing innovations using advanced analytics technologies, such as artificial intelligence, to gain a competitive advantage. AI in life sciences analytics is employed to enhance data analysis, streamline drug discovery processes, optimize clinical trials, and facilitate personalized medicine by revealing insights from complex biological data. For example, in September 2023, SAS Health, a healthcare technology company based in India, launched a groundbreaking healthcare platform designed to simplify health data management, improve data governance, and expedite patient insights. This comprehensive enterprise solution for analytics and data automation will provide healthcare providers, insurers, and public health agencies with the agility needed to foster innovations that enhance patient experiences and outcomes. Utilizing a unified health data model with mappings to industry standards, SAS Health will support the proactive identification of clinical staffing gaps and visualization of screening centers in relation to patient populations. Powered by the SAS Viya AI platform, it offers rapid access to actionable insights while ensuring compliance with regulations.

In July 2022, Trinity Life Sciences strategically acquired D Cube Analytics, a healthcare analytics company based in Illinois, for an undisclosed amount. This acquisition enhances Trinity's product offerings by incorporating extensive data science and digital transformation capabilities. The move underscores the significance of data analytics in the evolving landscape of life sciences commercialization services.

Major companies operating in the life science analytics market include Oracle Corporation., Accenture plc., SAS Institute Inc., International Business Machines Corporation (IBM), IQVIA Holdings Inc., Wipro Limited, Cognizant Technology Solutions Corporation, SCIOInspire Corp., Cerner Corporation, Optum Inc., Microsoft Corporation, MaxisIT Inc., Cotiviti Holdings Inc., Allscripts Healthcare Solutions Inc., ExlService Holdings Inc., Inovalon Holdings Inc., CitiusTech Inc., Saama Technologies LLC., Axtria Inc., Clarivate Plc, ThoughtSphere Ltd., ThoughtSpot Inc., Alteryx Inc., TAKE Solutions Ltd., Dynata LLC., M3 EU Ltd., BioSymetrics Inc., PerkinElmer Inc., Medidata Solutions Inc., PAREXEL International Corporation

North America was the largest region in the life science analytics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science analytics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the life science analytics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The life science analytics market includes revenues earned by entities by reporting, diagnostic and discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Life Science Analytics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on life science analytics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for life science analytics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The life science analytics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Life Science Analytics Market Characteristics

3. Life Science Analytics Market Trends And Strategies

4. Life Science Analytics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Life Science Analytics Growth Analysis And Strategic Analysis Framework

6. Life Science Analytics Market Segmentation

7. Life Science Analytics Market Regional And Country Analysis

8. Asia-Pacific Life Science Analytics Market

9. China Life Science Analytics Market

10. India Life Science Analytics Market

11. Japan Life Science Analytics Market

12. Australia Life Science Analytics Market

13. Indonesia Life Science Analytics Market

14. South Korea Life Science Analytics Market

15. Western Europe Life Science Analytics Market

16. UK Life Science Analytics Market

17. Germany Life Science Analytics Market

18. France Life Science Analytics Market

19. Italy Life Science Analytics Market

20. Spain Life Science Analytics Market

21. Eastern Europe Life Science Analytics Market

22. Russia Life Science Analytics Market

23. North America Life Science Analytics Market

24. USA Life Science Analytics Market

25. Canada Life Science Analytics Market

26. South America Life Science Analytics Market

27. Brazil Life Science Analytics Market

28. Middle East Life Science Analytics Market

29. Africa Life Science Analytics Market

30. Life Science Analytics Market Competitive Landscape And Company Profiles

31. Life Science Analytics Market Other Major And Innovative Companies

32. Global Life Science Analytics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Life Science Analytics Market

34. Recent Developments In The Life Science Analytics Market

35. Life Science Analytics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기